<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04283903</url>
  </required_header>
  <id_info>
    <org_study_id>Metabol_Proteom_Implants</org_study_id>
    <nct_id>NCT04283903</nct_id>
  </id_info>
  <brief_title>Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases</brief_title>
  <official_title>Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eklund Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SEPA (Sociedad Espa√±ola de Periodoncia)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to the limited efficacy of its treatment modalities, there is a stringent need to improve
      the prevention and early diagnosis of peri-implantitis. In fact, to date clinical and
      radiographic tools are not able to discern which patients are going to develop
      peri-implantitis and, among the ones already with peri-implantitis, which ones are currently
      loosing bone and which ones are going to progress.

      This project aims to analyze for the first time the whole large scale proteome and metabolome
      of peri-implant crevicular fluid (PICF) with an integrated approach from implants with
      peri-implant diseases.

      Twenty-five patients with at least one implant with peri-implant mucositis and one implant
      with peri-implantitis will be selected. For each of the selected participants, the PICF from
      an implant with peri-implant mucositis and from an implant with peri-implantitis will be
      sampled two different times before treatment. One year after the corresponding treatment is
      provided, the PICF of the treated implants with peri-implantitis will be sampled again.

      Both proteomic and metabolomic profiling of the samples will be carried out. The most
      important strength of this project will be the ability to evaluate together the whole
      proteome and the whole metabolome and to integrate them in the same framework.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peri-implant diseases presence</measure>
    <time_frame>Baseline (cross-sectional part)</time_frame>
    <description>Presence or absence of peri-implant mucositis or peri-implantitis according to the 2017 World Workshop (Berglundh et al. 2018)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease resolution of peri-implantitis</measure>
    <time_frame>1-year after treatment (longitudinal part)</time_frame>
    <description>According to the criteria proposed by Sanz &amp; Chapple (2012)</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <condition>Peri-Implantitis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PICF</intervention_name>
    <description>PICF collection from 4 sites</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        According to a study with a similar design on periodontitis (Barnes et al. 2009),
        twenty-five patients with at least one implant with peri-implantitis and one implant with
        peri-implant mucositis (Berglundh et al. 2018) will be selected in Complutense University
        of Madrid for PICF collection, before any treatment is provided. This will be done with the
        aim of excluding potential inter-individual variability in the metabolomic and proteomic
        profile of PICF.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least one implant with peri-implant mucositis and one with peri-implantitis

        Exclusion Criteria:

          -  Previously treated implants to be included
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mario Romandini</last_name>
    <phone>+393801563046</phone>
    <email>maromand@ucm.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Periodontology, University Complutense Madrid, Spain</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Sanz Alonso</last_name>
    </contact>
    <investigator>
      <last_name>Mario Romandini</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariano Sanz Alonso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2020</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

